Thursday 14 November 2024

The Pharmaletter

One To Watch

samsung

Samsung Bioepis

Want to Update your Company's Profile?


Latest Samsung Bioepis News

Samsung Bioepis’ latest US biosimilar market report
11 October 2024
Latest batch of EMA’s human medicines committee recommendations
20 September 2024
Six new biosimilars recommend for approval in Europe
27 July 2024
Sandoz launches biosimilar Pyzchiva across Europe
25 July 2024
More Samsung Bioepis news >


Today's issue

MeiraGTx wins 3 Rare Pediatric designations and updates on AAV-AIPL1
Biotechnology
MeiraGTx wins 3 Rare Pediatric designations and updates on AAV-AIPL1
13 November 2024
Pharmaceutical
Lenacapavir efficacy shown in diverse range of patients
13 November 2024
Pharmaceutical
BRIEF—Amgen dismisses obesity drug safety concern; investors unsure
13 November 2024
Biotechnology
Nippon Shinyaku and Atsena Thera collaborate on ATSN-101
13 November 2024
Biotechnology
UCB and Biogen’s dapirolizumab pegol paves new path for SLE treatment
13 November 2024
Biotechnology
Insilico’s IPF data an early indicator of AI potential
13 November 2024
Biotechnology
Sunshine calls on Apollo for work on novel bi-specific
13 November 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze